European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience

by A. T. van der Ploeg, M. Ую Kruijshaar, A. Toscano, P. Laforet, C. Angelini, R. H. Lachmann, S. I. Pascual Pascual, M. Roberts, K. Rosler, T. Stulnig, P. A. van Doorn, P.Y. K. Van den Bergh, J. Vissing, B. Schoser
Published 2019-01-01

Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients

by J. J. A. van den Dorpel, E. Poelman, L. Harlaar, H. A. van Kooten, L. J. van der Giessen, P. A. van Doorn, A. T. van der Ploeg, J. M. P. van den Hout, N. A. M. E. van der Beek
Published 2020-09-01